COL23A1 and nonpapillary renal cell carcinoma: To the best of our knowledge, this is the first comprehensive study establishing that COL23A1 plays an oncogenic role in ccRCC tumorigenesis and progression and has the potential to be a novel biomarker for predicting prognosis of ccRCC patients.